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OdourAbstract Ten new derivatives of isophorone were obtained through a five-step synthesis. Among
the products were several unsaturated, bicyclic lactones with three or four methyl groups. These
lactones were used as the substrates for biotransformation mediated by selected fungal strains
(Fusarium species, Syncephalastrum racemosum, Cunninghamella japonica, Penicillium species,
Absidia species, and Pleurotus ostreatus). Four new hydroxylactones were obtained as a result of
biotransformation. Because the unsaturated lactone with four methyl groups was a diastereoiso-
meric mixture, a structural analysis was conducted. The hydroxylactones were also included in this
analysis. Both the unsaturated lactones and hydroxylactones were examined for their antimicrobial
activity. It was found that some of these compounds exhibited growth inhibition against pathogenic
strains of bacteria (Staphylococcus aureus, Pseudomonas fluorescens), yeasts (Candida albicans) and
filamentous fungi (Alternaria sp., Penicillium sp.). All obtained compounds were also subjected to
scent analysis.
 2016 King Saud University. Production and Hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Modern medicine continues to search for new drugs and
preparations to combat diseases caused by ubiquitous bacteria,
viruses and fungi. Infections caused by these pathogens
decrease the quality of life of the average inhabitant of the
earth. Environmental pollution, poor nutrition and abuse of
all kinds of pharmaceuticals leave us particularly susceptible
to infections of all kinds of pathogens. Among the bacteria,ally and
2 K. Win´ska et al.the main group of unicellular prokaryotic organisms, Staphy-
lococcus aureus is extremely dangerous. This Gram-positive
bacterium can cause necrotizing pneumonia, endocarditis or
toxic shock syndrome, among others. Strains of this micro-
organism that are resistant to methicillin cause the majority
of hospital-acquired infections in the world [1]. Another com-
monly occurring drug-resistant bacterium, Pseudomonas fluo-
rescens, may cause infections of the urinary tract, meninges,
bones, joints, and others [2].
In addition, long-term use of antimicrobial therapy or
chemotherapeutic agents can cause an imbalance of bacteria
normally present in the colon. This results in weakened immu-
nity, leaving the patient particularly susceptible to Candida
fungal infections [3]. Populations particularly vulnerable to
candidiasis include patients struggling with chronic illnesses
such as diabetes, eating disorders and absorption, cancer and
blood disorders [4]. Filamentous fungi, such as those of the
genus Alternaria and Penicillium are equally dangerous, and
their spores can cause inhaled allergies [5].
More and more mutating pathogens have become resistant
to currently available drugs. For this reason, it is very impor-
tant to search for new chemical compounds able to replace
those compounds that are no longer active. Especially note-
worthy to this search are plant extracts used in traditional folk
medicine. Very often, the compounds of these isolates with
specific biological properties are molecules containing a lac-
tone ring. Particular attention should be paid to hydroxylac-
tones, many of which exert anticancer [6–9], anti-
inflammatory [10–12], antiviral [13,14], antifungal [15–17], or
antibacterial [18,19] activities. Such compounds are not only
derived solely from plant material; they may also be produced
by chemical synthesis [20–22] or biotransformation [23–27].
For more than ten years our team has been obtaining new
hydroxylactones from the chemically derived halolactones [23–
27]. For this purpose we use filamentous fungi capable of per-
forming hydrolytic dehalogenation. This method allows us to
obtain compounds whose acquisition by standard chemical
synthesis would be either impossible, or too complex to be
viable. In the presented work, we used unsaturated lactones
as substrates, hoping to obtain new derivatives with interesting
biological properties.
2. Experimental
2.1. Chemistry
Analytical TLC was performed on silica gel-coated aluminium
plates (DC-Alufolien Kieselgel 60 F254, Merck, Darmstadt,
Germany) with a mixture of hexane, acetone and diethyl ether
in various ratios. Compounds were detected by spraying the
plates with 1% Ce(SO4)2, 2% H3[P(Mo3O10)4] in 10%
H2SO4 or 20% ethanolic H2SO4, containing 0.1% of anisalde-
hyde, followed by heating to 120 C. Preparative column chro-
matography was performed on silica gel (Kieselgel 60, 230–400
mesh ASTM, Merck, Dramstadt, Germany) with a mixture of
hexane, acetone and diethyl ether (in various ratios) as eluents.
GC analysis was carried out on an Agilent Technologies
6890N (Varian, Agilent Technologies, Santa Clara, CA,
USA) instrument using a DB-17 column (cross-linked methyl
silicone gum, 30 m  0.32 mm  0.25 lm) or on a Varian
CP3380 (Varian, Agilent Technologies, Santa Clara, CA,Please cite this article in press as: K. Win´ska et al., Antimicrobial activity of new bic
biosynthetically, Journal of Saudi Chemical Society (2016), http://dx.doi.org/10.101USA) instrument using the Thermo TR-5
(30 m  0.32 mm  1.0 lm) capillary columns:. The molar
masses of the obtained compounds were confirmed by a high
resolution mass spectrometry analysis using a Waters GCT
Premier instrument (ESI ionization) (Waters Division, Mil-
ford, Massachusetts). An enantiomeric excess of the products
obtained during biotransformation was determined by GC
analysis using the chiral column CP-cyclodextrin-B-325
(30 m  0.25 mm  0.25 lm) under the following conditions:
injector 200 C, detector (FID) 220 C, column temperature:
140 C (hold 45 min), 140–200 C (rate 20 C/min), 200 C
(hold 1 min). Optical rotations were determined on a P-2000
polarimeter (Jasco Easton, PA, USA) in chloroform solutions,
whose concentrations are denoted in g/100 mL. The melting
points were determined on a Boetius apparatus. The refractive
index was measured on a Carl Zeiss Abbe and Pulfrich refrac-
tometer (Jena, Germany).
NMR spectra were recorded in CDCl3 solution on a Bruker
Avance DRX 300 MHz spectrometer (Bruker, Billerica, MA,
USA) or on a Bruker Avance 600 MHz spectrometer (Bruker,
Billerica, MA, USA). IR spectra were recorded on a Thermo-
Nicolet IR 300 FT-IR spectrometer (Waltham, MA, USA).
2.1.1. Synthesis
The commercially available ketone, isophorone (1), was pur-
chased from Fluka. The known allyl alcohol 2 was obtained
according to the method described by Magnusson and Thoren
[28]. All of the subsequent products were obtained according
to procedures that are described below:
2.1.1.1. General procedure for the synthesis of ethyl esters
(3a-b). Ester 3a (1.14 g, 5.42 mmol, yield 95%) was obtained
as a product of the Claisen rearrangement with orthoacetate
modification [29] and ester 3b (two diastereoisomers) (1.44 g,
6.44 mmol, yield 80%) was obtained in the same manner as
the first one, but with orthopropionate modification character-
ized by the data given below.
2.1.1.1.1. Ethyl (3,5,5-trimethylcyclohex-2-en-1-yl)acetate
(3a). 3a: nD = 1.4618; IR (KBr): 2954, 1736, 1456, 1368,
1269, 1180, 1033 cm1; 1H NMR (300 MHz, CDCl3): d 0.87
(s, 3H, CH3-10), 0.95 (s, 3H, CH3-11), 1.26 (t, J= 7.1 Hz,
3H, CH3-13), 1.52 (m, 2H, CH2-6), 1.58 (d, J= 17.3 Hz, 1H,
one of CH2-4), 1.63 (s, 3H, CH3-9), 1.80 (dm, J= 17.3 Hz,
1H, one of CH2-4), 2.23 (dd, J= 9.6 and 9.6 Hz, 2H, CH2-
7), 2.60 (m, 1H, H-1), 4.14 (q, J= 7.1 Hz, 2H, CH2-12),
5.20 (s, 1H, H-2) ppm; 13C NMR (300 MHz, CDCl3): 14.33
(C-13), 23.90 (C-9), 25.36 (C-10), 29.98 (C-5), 31.12 (C-3),
31.84 (C-11), 41.28 (C-7), 42.31 (C-4), 44.08 (C-6), 60.22 (C-12),
122.77 (C-2), 133.95 (C-1), 173.10 (C-8) ppm; ESIHRMS: calcd
for C13H22O2, m/z 211.1692 (M+H)
+, found 211.1698.
2.1.1.1.2. Ethyl 2-(3,5,5-trimethylcyclohex-2-en-1-yl)pro-
panoate (3b). 3b: nD = 1.4542; IR (KBr): 2956, 1735, 1458,
1365, 1250, 1187, 1075 cm1; 1H NMR (300 MHz, CDCl3): d
0.86 (s, 3H, CH3-10), 0.95 (s, 3H, CH3-11), 1.00 (m, 1H, one
of CH2-6), 1.08 (d, J= 6.9 Hz, 3H, CH3-12), 1.26
(t, J= 7.1 Hz, 3H, CH3-14), 1.28 (m, 1H, one of CH2-6), 1.49
(m, 1H, one of CH2-4), 1.63 (s, 3H, CH3-9), 1.81 (m, 1H,
one of CH2-4), 2.32 (m, 1H, CH2-7), 2.42 (m, 1H, H-1), 4.15
(q, J= 7.1 Hz, 2H, CH2-13), 5.12 (s, 1H, H-2) ppm;
13C
NMR (300 MHz, CDCl3): 13.50 (C-12), 14.35 (C-14), 24.04
(C-9), 25.26 (C-10), 29.90 (C-5), 31.98 (C-11), 36.77 (C-4),yclic lactones with three or four methyl groups obtained both synthetically and
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(C-2), 134.23 (C-1), 176.25 (C-8) ppm; ESIHRMS: calcd for
C14H24O2, m/z 225.1849 (M+H)
+, found 225.1814.
2.1.1.2. General procedure for the synthesis of acids (4a-b).
Basic hydrolysis of esters 3a and 3b (two diastereoisomers)
according to the procedure described previously [30] gave
1.00 g (5.49 mmol, yield 70%) of acid 4a and 1.00 g
(5.09 mmol, yield 79%) of acid 4b (two diastereoisomers) with
the following physical and spectral data:
2.1.1.2.1. (3,5,5-Trimethylcyclohex-2-en-1-yl)acetic acid
(4a). 4a: nD = 1.4788; IR (KBr): 2950, 1706, 1459, 1364,
1213, 1166, 946 cm1; 1H NMR (300 MHz, CDCl3): d 0.88
(s, 3H, CH3-10), 0.96 (s, 3H, CH3-11), 1.48 (ddd, J= 12.6,
5.3 and 1.3 Hz, 2H, CH2-6), 1.56 (d, J= 17.4 Hz, 1H, one
of CH2-4), 1.64 (s, 3H, CH3-9), 1.80 (d, J= 17.4 Hz, 1H,
one of CH2-4), 2.30 (dd, J= 11.3 and 7.3 Hz, 2H, CH2-7),
2.59 (m, 1H, H-1), 5.23 (s, 1H, H-2); 13C NMR (300 MHz,
CDCl3): 23.88 (C-9), 25.33 (C-10), 29.98 (C-5), 30.90 (C-3),
31.81 (C-11), 40.79 (C-7), 42.24 (C-4), 44.06 (C-6), 122.43
(C-2), 134.36 (C-1), 178.17 (C-8), ppm; ESIHRMS: calcd for
C11H18O2 m/z 183.1380 (M+H)
+, found 183.1385.
2.1.1.2.2. 2-(3,5,5-Trimethylcyclohex-2-en-1-yl)propanoic
acid (4b). 4b: m.p. = 69–70 C; IR (KBr): 2950, 1706, 1458,
1365, 1262, 1213, 1165 cm1; 1H NMR (300 MHz, CDCl3): d
0.87 (s, 3H, CH3-10), 0.97 (s, 3H, CH3-11), 1.00 (m, 1H, one
of CH2-6), 1.12 (d, J= 6.9 Hz, 3H, CH3-12), 1.34 (m, 1H,
one of CH2-6), 1.55 (d, J= 17.1 Hz, 1H, one of CH2-4),
1.65 (s, 3H, CH3-9), 1.80 (d, J= 17.1 Hz, 1H, one of CH2-
4), 2.40 (m, 1H, CH2-7), 2.49 (m, 1H, H-1), 5.18 (s, 1H, H-2)
ppm; 13C NMR (300 MHz, CDCl3): 13.15 (C-12), 24.00
(C-9), 24.10 (C-9), 25.23 (C-10), 29.92 (C-5), 31.97 (C-11),
32.06 (C-11), 36.50 (C-3), 36.60 (C-3), 38.01 (C-4), 40.04 (C-
4), 43.79 (C-7), 44.05 (C-7), 44.17 (C-6), 120.04 (C-2), 121.80
(C-2), 134.71 (C-1), 135.18 (C-1), 181.82 (C-8), 182.77 (C-8)
ppm; ESIHRMS: calcd for C12H20O2, m/z 197.1536 (M
+H)+, found 197.1542.
2.1.1.3. Procedure for synthesis of bromolactone (5a) and
lactone (6a). According to the known procedure [23] we
obtained 0.25 g (yield 23%) of bromolactone 5a and 0.69 g
(yield 70%) unsaturated lactone 6a from 1 g of acid 4a. Dehy-
drodehalogenation of this mixture, according to the known
procedure [30], gave 0.81 g (yield 82%) of unsaturated lactone
6a characterized by the data presented below:
2.1.1.3.1. 2-Bromo-2,4,4-trimethyl-9-oxabicyclo[4.3.0]nonan-8-
one (5a). 5a: oil; IR (KBr): 2956, 1781, 1454, 1364, 1212, 1166,
975 cm1; 1H NMR (300 MHz, CDCl3): d 0.93 (s, 3H, CH3-
10), 1.02 (dd, J= 13.2 Hz, 1H, one of CH2-5), 1.24 (s, 3H,
CH3-11), 1.45 (ddd, J= 10.4, 5.4 and 2.3 Hz, 1H, one of
CH2-5), 1.68 (d, J= 15.8 Hz, 1H, one of CH2-3), 1.93 (s,
3H, CH3-9), 1.98 (dm, J= 15.8 Hz, 1H, one of CH2-3), 2.25
(d, J= 16.6 Hz, 1H, one of CH2-7), 2.75 (dd, J= 16.6 and
6.1 Hz, 2H, CH2-7), 2.87 (m, 1H, H-6), 4.64 (d, J= 3.4 Hz,
1H, H-1) ppm; 13C NMR (300 MHz, CDCl3): 26.34 (C-9),
30.51 (C-4), 31.54 (C-6), 33.28 (C-10), 34.30 (C-11), 38.76
(C-7), 38.91 (C-5), 47.90 (C-3), 61.43 (C-2), 84.50 (C-1),
176.04 (C-8) ppm; ESIHRMS: calcd for C11H17BrO2, m/z
261.0485 (M+H)+, found 261.0490.
2.1.1.3.2. 2,4,4-Trimethyl-9-oxabicyclo[4.3.0]non-2-en-8-
one (6a). 6a: nD = 1.4932; IR (KBr): 2958, 1783, 1452,
1358, 1210, 1165, 972 cm1; 1H NMR (300 MHz, CDCl3):Please cite this article in press as: K. Win´ska et al., Antimicrobial activity of new bic
biosynthetically, Journal of Saudi Chemical Society (2016), http://dx.doi.org/10.101d= 0.97 (s, 3H, CH3-10), 1.01 (s, 3H, CH3-11), 1.22 (dd,
J= 12.4 and 13.3 Hz, 1H, one of CH2-5), 1.45 (ddd,
J= 13.2, 12.8 and 4.7 Hz, 1H, one of CH2-5), 1.82 (s, 3H,
CH3-9), 2.28 (d, J= 17.4 Hz, 1H, one of CH2-7), 2.65 (m,
1H, H-6), 2.87 (dd, J= 17.4 and 8.0 Hz, 2H, CH2-7), 4.54
(d, J= 5.4 Hz, 1H, H-1), 5.55 (s, 1H, H-3) ppm; 13C NMR
(300 MHz, CDCl3): 21.15 (C-9), 26.92 (C-10), 30.61 (C-11),
31.37 (C-4), 36.81 (C-7), 38.82 (C-5), 79.23 (C-1), 44.06 (C-6),
32.33 (C-4), 127.17 (C-2), 139.45 (C-3), 176.80 (C-8) ppm;
ESIHRMS: calcd for C11H16O2, m/z 181.1223 (M+H)
+, found
181.1228.
2.1.1.4. Procedure for synthesis of bromolactone (5b) and
lactone (6b). Using the same conditions described above and
1.00 g of acid 4b (two diastereoisomers) we obtained the mix-
ture of bromolactone 5b (two diastereoisomers) (0.83 g, 59%)
and unsaturated lactone 6b (two diastereoisomers) (0.30 g,
30%). Dehydrodehalogenation of this mixture gave 0.77 g
(78%) of unsaturated lactone 6b as a diastereoisomeric mix-
ture (40% A, 60% B) with the following physical and spectral
data:
2.1.1.4.1. 2-Bromo-2,4,4,7-tetramethyl-9-oxabicyclo[4.3.0]
nonan-8-one (5b). 5b: m.p. = 54–55 C; IR (KBr): 2955,
1772, 1454, 1197, 1166, 970 cm1; 1H NMR (300 MHz,
CDCl3): d 0.92 (s, 3H, CH3-10 B), 0.94 (s, 3H, CH3-10 A),
1.02 (m, 2H, CH2-5 B), 1.20 (d, J= 7.0 Hz, 3H, CH3-12 B),
1.22 (s, 3H, CH3-11 A), 1.23 (s, 3H, CH3-11 B), 1.33 (dd,
J= 7.5 Hz, 3H, CH2-12 A), 1.46 (ddd, J= 13.8, 5.4 and
2.1 Hz, 2H, CH2-5 A), 1.68 (dd, J= 15.6 and 8.4 Hz, 2H,
CH2-3 A), 1.93 (s, 3H, CH3-9 B), 1.94 (s, 3H, CH3-9 A),
2.00 (m, 2H, CH2-3 B), 2.38 (q, J= 7.6 Hz, 1H, H-7 A),
2.52 (ddd, J= 12.8, 5.4 and 3.7 Hz, 1H, H-6 A), 2.81 (m,
1H, H-6 B), 2.87 (m, 1H, H-7 B), 4.54 (d, J= 2.5 Hz, 1H,
H-1 B), 4.77 (d, J= 3.7 Hz, 1H, H-1 A) ppm; 13C NMR
(300 MHz, CDCl3): 9.16 (C-12 B), 13.67 (C-12 A), 26.37
(C-11 A), 27.22 (C-11 B), 30.43 (C-5 B), 33.37 (C-9 B), 34.28
(C-9 A), 34.43 (C-10 A), 34.53 (C-10 B), 35.85 (C-4 B), 35.88
(C-4 A), 37.94 (C-6 A), 39.53 (C-5 A), 42.57 (C-3 B), 43.23
(C-6 B), 45.11 (C-7 A), 48.15 (C-3 A), 61.65 (C-7 B), 82.65
(C-1 A), 82.95 (C-1 B), 139.21 (C-2 A), 139.35 (C-2 B),
178.46 (C-8 B), 179.26 (C-8 A) ppm; ESIHRMS: calcd for C12-
H19BrO2 m/z 275.0641(M+H)
+, found 275.0653.
2.1.1.4.2. 2,4,4,7-Tetramethyl-9-oxabicyclo[4.3.0]non-2-en-
8-one (6b). 6b: nD = 1.4871; IR (KBr): 2968, 1772, 1458,
1169, 974 cm1; 1H NMR (300 MHz, CDCl3): d 0.95 (s, 3H,
CH3-10 B), 0.96 (s, 3H, CH3-10 A), 1.00 (s, 3H, CH3-11 B),
1.02 (s, 3H, CH3-11 A), 1.04 (d, J= 14.3 Hz, 1H, one of
CH2-5 B), 1.18 (d, J= 7.3 Hz, 3H, CH3-12 B),), 1.25 (d,
J= 13.2 Hz, 1H, one of CH2-5 A), 1.39 (d, J= 7.7 Hz, 3H,
CH3-12 A), 1.40 (ddd, J= 14.3, 4.5 and 1.2 Hz, 1H, one of
CH2-5 B), 1.48 (ddd, J= 13.2, 4.8 and 1.2 Hz, 1H, one of
CH2-5 A), 1.82 (s, 6H, CH3-9 A, CH3-9 B), 2.28 (m, 1H,
H-6 A), 2.39 (qd, J= 7.7 and 1.2 Hz, 1H, H-7 A), 2.64
(m, 1H, H-6 B), 2.94 (m, 1H, H-7 B), 4.23 (d, J= 5.0 Hz, 1H,
H-1 B), 4.62 (d, J= 5.7 Hz, 1H, H-1 A), 5.53 (s, 2H, H-3 A,
H-3 B) ppm; 13C NMR (300 MHz, CDCl3): 9.35 (C-12 B),
15.62 (C-12 A), 21.06 (C-9 A), 26.94 (C-10 B), 26.94 (C-10
B), 27.22 (C-10 A), 28.48 (C-11 B), 30.55 (C-11 A), 32.06
(C-4 B), 32.20 (C-4 A), 33.61 (C-5 B), 35.85 (C-6 B), 38.71
(C-5 A), 39.03 (C-6 A), 39.96 (C-7 B), 43.26 (C-7 A), 77.40
(C-1 A), 77.44 (C-1 B), 127.17 (C-2 B), 127.18 (C-2 A),
139.22 (C-3 A), 139.37 (C-3 B), 175.39 (C-8 B), 179.97yclic lactones with three or four methyl groups obtained both synthetically and
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(M+H)+, found 195.1385.2.2. Biotransformations
2.2.1. Microorganisms
All of the fungal strains that were used in the biotransfor-
mations came from the collection of the Institute of Biology
and Botany, Medical University, Wrocław (Fusarium culmo-
rum AM10, Fusarium avenaceum AM11, Fusarium oxyspo-
rum AM13, Fusarium tricinctum AM16, Fusarium
semitectum AM20, Fusarium equiseti AM22, Fusarium scirpi
AM199, F. culmorum AM196, Fusarium solani AM203, Syn-
cephalastrum racemosum AM105, Cunninghamella japonica
AM472, Penicillium vermiculatum AM30, Penicillium cher-
mesinum AM113, Penicillium frequentans AM351, Absidia
coerulea AM93, Absidia cylindrospora AM336, Pleurotus
ostreatus AM600). These strains were cultivated on Sabour-
aud’s agar containing 0.5% aminobac, 0.5% peptone, 4%
glucose and 1.5% agar dissolved in distilled water at 28 C
and stored in a refrigerator at 4 C.
2.2.1.1. Screening biotransformation. The fungal strains used
for the biotransformations were cultivated at 25 C in two
Erlenmeyer flasks (300 mL). Each flask contained 100 mL
of medium consisting of 3% glucose and 1% bacteriological
peptone (Biocorp). After three days, 10 mg of the substrate
dissolved in 1 mL of acetone was added to each flask with
the grown culture. Incubation of the shaken cultures with
substrate was continued for 14 days. After 5, 9 and 14 days
of incubation, the mixture of unreacted substrate, products
and mycelium were extracted with dichloromethane
(15 mL) and analyzed by GC (DB-17 column).
2.2.1.2. Preparative biotransformation. A total of 100 mg of
halolactone 3–5 was dissolved in 10 mL acetone and dis-
tributed between 10 Erlenmeyer flasks (300 mL) with the
3-day fungal strains cultures that were prepared as described
above. Microorganisms that were able to form any product
were incubated with substrate for 14 days and then the pro-
duct mixture was extracted with dichloromethane
(3  40 mL). Combined organic fractions were dried over
anhydrous magnesium sulfate and the solvent was evapo-
rated in vacuo and subsequently, pure product was separated
from the unreacted substrate and the metabolites of the
fungi by column chromatography (silica gel, hexane:acetone
3:1).
The physical and spectral data of the hydroxylactones
obtained during biotransformation are presented below:
2.2.1.2.1. 9-Hydroxy-2,4,4-trimethyl-9-oxabicyclo[4.3.0]
nonan-8-one (7a). Oil; IR (KBr): 3438, 2957, 1751, 1471,
1213, 1170 cm1; 1H NMR (300 MHz, CDCl3): d 1.00
(s, 3H, CH3-10), 1.05 (s, 3H, CH3-11), 1.24 (dd, J= 13.7
and 13.7 Hz, 1H, one of CH2-5), 1.50 (ddd, J= 13.2, 4.7
and 1.2 Hz, 1H, one of CH2-5), 1.88 (m, 1H, OH), 2.25
(d, J= 17.5 Hz, 1H, one of CH2-7), 2.68 (m, 1H, H-6), 2.89
(dd, J= 17.5 and 8.0 Hz, 1H, one of CH2-7), 4.20 (dd,
J= 4.3 and 0.9 Hz, 2H, CH2-9), 4.81 (d, J= 5.4 Hz, 1H, H-
1), 5.86 (s, 1H, H-3) ppm; 13C NMR (300 MHz, CDCl3):
26.76 (C-10), 30.29 (C-11), 31.24 (C-6), 32.23 (C-4), 36.57
(C-7), 38.84 (C-5), 64.76 (C-9), 75.48 (C-1), 130.83 (C-2),Please cite this article in press as: K. Win´ska et al., Antimicrobial activity of new bic
biosynthetically, Journal of Saudi Chemical Society (2016), http://dx.doi.org/10.101140.82 (C-3), 176.60 (C-8) ppm; ESIHRMS: calcd for
C11H16O2, m/z 181.1223 (M+H)
+, found 181.1228.
2.2.1.2.2. 9-Hydroxy-2,4,4,7-tetramethyl-9-oxabicyclo
[4.3.0]nonan-8-one (7b). Oil; IR (KBr): 3444, 2958, 1766,
1457, 1198, 962 cm1; 1H NMR (300 MHz, CDCl3): d 1.03
(s, 3H, CH3-10), 1.08 (s, 3H, CH3-11), 1.30 (dd, J= 13.4
and 13.3 Hz, 1H, one of CH2-5), 1.41 (d, J= 7.6 Hz, 3H,
CH3-12), 1.56 (dd, J= 13.4 and 4.8 Hz, 1H, one of CH2-5),
1.72 (m, 1H, OH), 2.34 (m, 1H, H-6), 2.41 (m, 1H, H-7),
4.24 (d, J= 16.2 Hz, 2H, CH2-9), 4.94 (d, J= 5.6 Hz, 1H,
H-1), 5.87 (s, 1H, H-3) ppm; 13C NMR (300 MHz, CDCl3):
15.54 (C-12), 27.00 (C-10), 30.24 (C-11), 32.11 (C-4), 38.75
(C-5), 38.81 (C-6), 43.06 (C-7), 64.85 (C-9), 73.68 (C-1),
130.82 (C-2), 140.66 (C-3), 179.62 (C-8) ppm; ESIHRMS:
calcd for C12H18O3, m/z 211.1329 (M+H)
+, found 211.1334.
2.2.1.2.3. 11-Hydroxy-2,4,4,7-tetramethyl-9-oxabicyclo
[4.3.0]nonan-8-one (8b). Oil; IR (KBr): 3420, 2958, 1767,
1457, 1197, 963 cm1; 1H NMR (300 MHz, CDCl3): d 1.03
(s, 3H, CH3-10), 1.22 (dd, J= 7.2 and 5.1 Hz, 1H, one of
CH2-5), 1.37 (d, J= 7.6 Hz, 3H, CH3-12), 1.65 (m, 1H,
OH), 1.84 (dd, J= 13.5 and 5.1 Hz, 1H, one of CH2-5), 2.42
(qd, J= 7.6 and 1.6 Hz, 1H, H-7), 2.48 (m, 1H, H-6), 3.85
(d, J= 1.8 Hz, 2H, CH2-11), 4.69 (d, J= 5.7 Hz, 1H, H-1),
5.49 (s, 1H, H-3) ppm; 13C NMR (300 MHz, CDCl3): 15.48
(C-12), 21.28 (C-9), 25.10 (C-10), 30.60 (C-5), 37.61 (C-4),
39.00 (C-6), 43.13 (C-7), 69.38 (C-11), 77.07 (C-1), 131.73
(C-2), 134.14 (C-3), 179.75 (C-8) ppm; ESIHRMS: calcd for
C12H18O3Na, m/z 233.1215 (M+Na)
+, found 233.1154.
2.2.1.2.4. 7-Hydroxy-2,4,4,7-tetramethyl-9-oxabicyclo[4.3.0]
nonan-8-one (9b). Oil; IR (KBr): 3444, 2959, 1775, 1451,
1204 cm1, 1H NMR (300 MHz, CDCl3): d 0.94 (d,
J= 13.6 Hz, 1H, one of CH2-5), 0.98 (s, 3H, CH3-10), 1.03
(s, 3H, CH3-11), 1.37 (m, 1H, one of CH2-5), 1.41 (s, 3H,
CH3-12), 1.60 (m, 1H, OH), 1.84 (s, 3H, CH3-9), 2.48 (dt,
J= 14.5 and 4.2 Hz, 1H, H-6), 4.83 (d, J= 4.8 Hz, 1H, H-
1), 5.54 (s, 1H, H-3) ppm; 13C NMR (300 MHz, CDCl3):
19.36 (C-12), 21.00 (C-9), 26.90 (C-10), 30.74 (C-11), 32.27
(C-4), 34.11 (C-5), 42.52 (C-6), 77.63 (C-1), 127.07 (C-2),
139.19 (C-3), 177.05 (C-7), 177.10 (C-8) ppm; ESIHRMS:
calcd for C12H18O3, m/z 211.1329 (M+H)
+, found 211.1334.
2.2.1.3. Bioassay. Tests were made using the following strains
of bacteria: Escherichia coli C1, S. aureus, Bacillus subtilis
B5, P. fluorescens W1; yeast: Candida albicans KL-1, Yarrowia
lipolytica ATCC 20460, Saccharomyces cerevisiae SV30; and
filamentous fungal: Alternaria sp., Fusarium linii A3, Aspergil-
lus niger XP, Penicillium sp. These strains came from the col-
lection at the Department of Biotechnology and Food
Microbiology, Wroclaw University of Environmental and Life
Sciences. The tests were performed on the automated Bio-
screen C system (Automated Growth Curve Analysis System,
Lab Systems, Finland) following the procedure below. The
bacterial cultures were carried out for 48 h in a liquid broth
containing 15 g of dry bullion (Biocorp) and 10 g of glucose
dissolved in 1 L of distilled water. Yeast and fungi were cul-
tured in YPG medium containing 10 g of yeast extract, 10 g
of bacteriological peptone and 10 g of glucose dissolved in
1 L of distilled water for 48 and 96 h, respectively. The work-
ing volume in the wells of the Bioscreen plate was 300 lL,
comprising 280 lL of culture medium, and 10 lL of cell or
spore solution (final density 1  106 cells mL1). Unsaturated
lactones and hydroxylactones were dissolved in 10 lL dimethylyclic lactones with three or four methyl groups obtained both synthetically and
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Antimicrobial activity of new bicyclic lactones 5sulfoxide and used at a final concentration of 0.1% (w/v). The
temperatures were controlled to 30 C (bacteria, yeasts) and
25 C (filamentous fungi). The optical densities of the cell sus-
pensions were measured automatically at 560 nm at regular
intervals of 30 min., for 2–4 days. The cell cultures were placed
on a continuous shaker. Each culture was performed in three
replicates.
The data were analyzed using spreadsheet software (Excel
97) and the means for the triplicates of each culture medium
type were calculated. The mean values were used to generate
the growth curves for each investigated strain, constituting a
function of the incubation time and the culture medium absor-
bency. The resulting microbial growth curves were compared
to control cultures in the medium supplemented with dimethyl
sulfoxide.
2.3. Odour evaluation
The odour evaluation was performed for ethanolic solutions
(10%) of samples with the use of a strip blotter. The samples
were judged by the five experienced panellists who evaluated
the odour characteristics of new compounds according to liter-
ature [27,31,32].
3. Results and discussion
3.1. Chemistry
Two racemic unsaturated lactones 6a and 6b were synthesised
from the commercially available ketone isophorone 1. The first
known allyl alcohol 2 was synthesised using the procedure
described earlier [28]. Obtained alcohol 2 was subjected to
Claisen rearrangement using triethyl orthoacetate [29] and tri-
ethyl orthopropionate, which led to the two esters 3a and 3b.
Basic hydrolysis of these esters led us to obtain two unsatu-
rated acids (4a,b) of which the second was a pair of diastere-
omers (we didn’t separate them). During the next step, we
tried to obtain bromolactones using a known procedure [23].
Unfortunately, during these reactions a mixture of bromolac-
tones (5a,b) and unsaturated lactones (6a,b) were obtained
with the latter predominating instead of the expected products.
An attempt to separate the products by column chromatogra-
phy allowed us only to increase the amount of unsaturated lac-
tone in the mixture. We were able to isolate only a small
amount of the bromolactones 5a and 5b. Therefore we decided
to perform a dehydrodehalogenation reaction using DBU in
toluene according to the known method [30]. As a result of
these reactions, the unsaturated lactones 6a and 6b, of which
the second was a mixture of two diastereoisomers, were
obtained. After isolation (in a small amount) of one of these
diastereoisomers (named A), the appropriate structures of
the two compounds (named A and B) were assigned
(Scheme 1).
The analysis of the NMR spectra allowed us to determine
the structures of particular compounds. In the case of ester
3a, a wide multiplet of proton H-1 suggested its axial position,
which proves that the carboetoxy group occupied an equato-
rial position. We could observe the same situation for acid
4a. Looking at spectra of bromolactone 5a and unsaturated
lactone 6a we could observe that proton H-6 had retained its
axial position (wide multiplet) and proton H-1 was in equato-Please cite this article in press as: K. Win´ska et al., Antimicrobial activity of new bic
biosynthetically, Journal of Saudi Chemical Society (2016), http://dx.doi.org/10.101rial position (Scheme 2). This observation suggested that the
cyclohexane ring was in the chair conformation. The presence
of the c-lactone ring in the molecules of lactones 5a and 6a was
confirmed by the IR spectra absorption bands at 1776 cm1
and 1781 cm1 for 5a and 6a, respectively.
Analysis of the NMR spectra of ester 3b and acid 4b proved
that proton H-1 occupied an axial position and was in an equa-
torial position, similar to the previous case. Adding an addi-
tional methyl group on carbon C-7 led to obtaining these
compounds as pairs of diastereoisomers.However, this was con-
firmed only by GC analysis. In the NMR spectra of lactone 6b,
an almost equimolar mixture of two diastereoisomers was
observed. The analysis of these spectra proved that the cyclohex-
ane ring was in the chair conformation. The wide multiplet of
proton H-6 indicated its axial position, while the shape of the
signal of proton H-1 demonstrated its equatorial position. An
additional methyl group at carbon C-7 was located across the
plane of the lactone ring (case A) or in the plane of lactone ring
(case B) (Scheme 3). This observation was proved by the fact
that in case A this signal was a multiplet which looked like a
quintet, while in caseB the signal fromH-7was a quartet of dou-
blets. The IR spectra absorption bands at 1772 cm1 for both of
the lactones confirmed the presence of the c-lactone ring.
3.2. Biotransformations
Research carried out by our team confirmed that most filamen-
tous fungi biotransformed unsaturated lactones to their oxy-
gen derivatives. A regioselective enzymatic hydroxylation or
epoxidation is catalyzed by oxygenases and specifically cyto-
chrome P-450 monooxygenase [33]. In the experiments con-
ducted earlier on similar systems, we observed the best
results for a strain of A. cylindrospora AM336. The unsatu-
rated lactone containing two methyl groups in cyclohexene
ring was hydroxylated by this strain with a good yield [34].
Also unsaturated bicyclic lactones with p-menthane system
are also transformed by this strain to hydroxyderivative.yclic lactones with three or four methyl groups obtained both synthetically and
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Table 1 Hydroxylation of unsaturated lactone 6a during
screening biotransformation.
Entry Strain Days Substrate
6a (%)
Product 7a
(%)
1 Penicillium
vermiculatum AM30
5 27.1 72.9
9 16.0 84.0
14 6.2 93.8
2 Absidia cylindrospora
AM336
5 82.9 –
9 40.7 16.1
14 14.4 21.2
3 Pleurotus ostreatus
AM600
5 100 –
9 62.8 37.2
14 34.4 65.6
The best results are highlighted in bold.
6 K. Win´ska et al.Transformation was carried out using not only A. cylin-
drospora but also Absidia glauca and S. racemosum [35]. On
the other hand tricyclic unsaturated lactone, for example iso-
drimenin was hydroxylated in allylic position by the strain Rhi-
zopus arrhizus [36].
In our previous research, we observed that the strain of A.
cylindrospora was able also to oxidize the double bond to the
oxirane ring in case of bicyclic unsaturated lactones with two
or three methyl groups in the cyclohexene ring. This effect
was due to the fact that allyl position was blocked by gem-
dimethyl-group [37] and it was impossible to obtain allyl
hydroxy derivative. Furthermore in bicyclic sesquiterpene lac-
tones with germacrene or guaiac system epoxidation of the
double bond by Cunninghamella echinulata was observed
[38]. Epoxidation of the double bond of tricyclic dehydrocos-
tus lactone was also observed by Xiao-Ci Ma [39]. This reac-
tion was catalyzed by fungus Aspergillus candidus and Mucor
polymorphosporus.
Both unsaturated lactones 6a and 6b (as a mixture of A and
B) obtained during synthesis were subjected to a screening bio-
transformation. We intended to determine which fungal strains
are able to introduce a hydroxy group into these lactones. We
chose the following strains: F. culmorum AM10, F. avenaceum
AM11, F. oxysporum AM13, F. tricinctum AM16, F. semitec-
tum AM20, F. equiseti AM22, F. scirpi AM199, F. culmorum
AM196, F. solani AM203, S. racemosum AM105, C. japonica
AM472, P. vermiculatum AM30, P. chermesinum AM113, P.
frequentans AM351, A. coerulea AM93, A. cylindrospora
AM336, and P. ostreateus AM600. The progress of each of
the screening transformations was monitored by means of
standard techniques (TLC and GC). Results of this step are
shown in Tables 1 and 2.
During the screening biotransformation, 17 different fungal
strains were tested. Only three or four were able to perform
hydroxylation of substrates 6a or 6b respectively. In the caseTable 2 Hydroxylation of unsaturated lactone 6b during screening
Entry Strain Days Substrate
1 Penicillium vermiculatum AM30 5 100
9 –
14 –
2 Syncephalastrum racemosum AM 105 5 75.2
9 57.3
14 48.7
3 Cunninghamella japonica AM472 5 100
9 81.8
14 66.3
4 Pleurotus ostreatus AM600 5 79.9
9 70.3
14 57.0
Please cite this article in press as: K. Win´ska et al., Antimicrobial activity of new bic
biosynthetically, Journal of Saudi Chemical Society (2016), http://dx.doi.org/10.101of lactone 6a only one product (7a) was present in every trans-
formation. When lactone 6b was used as a substrate, the for-
mation of three different products (7b, 8b and 9b) was
observed (Schemes 4 and 5).
In the next step, that is the preparative biotransformation,
we used only the fungal strains that were able to transform
substrates with yields exceeding 50%. During the preparative
scale biotransformation of unsaturated lactone 6a, one and
the same hydroxylactone 7a, which was the result of the substi-
tution of a hydroxy group in an allylic position, was obtained.
It is worth noting that of the two possible allylic positions (C-1
and C-9) only one was selected (at C-9) and it is probable that
this one was more accessible. Use of P. vermiculatum strain
allows to obtain the product 7a with 87.4% yield (according
to GC). In the case of P. ostreateus strain this lactone was cre-
ated with 61.9% yield. Isolated yields for these reactions were
23.6% (0.026 g) and 14.5% (0.016 g) respectively. Extremely
interesting for us is the fact that in the available literature we
did not find positive examples of hydroxylation using a strain
of Penicillium vermiculatum.
In the case of unsaturated lactone 6b, the formation of
hydroxylactone 7b, which was analogous to product 7a men-
tioned above, was also observed. However, in this case, two
other unexpected hydroxylactones were created: the first with
a hydroxy group substituted at methyl group C-11 (8b), andbiotransformation.
6b (%) Product 7b (%) Product 8b (%) Product 9b (%)
– –
44.3 55.7 –
44.3 55.7 –
– – 24.8
– – 42.7
– – 52.2
– – –
4.2 5.8 8.2
11.7 12.0 10.0
6.9 8.0 5.2
10.4 12.0 7.3
16.0 18.8 8.2
yclic lactones with three or four methyl groups obtained both synthetically and
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Antimicrobial activity of new bicyclic lactones 7the second in which carbon C-7 was attacked by a hydroxy
group (9b). The formation of the last product reveals a large
stereoselectivity bias of the microorganism that was able to
conduct this transformation. As was mentioned earlier, unsat-
urated lactone 6b, which was used as the substrate for bio-
transformation, was a mixture of two diastereoisomers (A,
B). Such situation caused that during the biotransformation,
catalyzed by P. vermiculatum AM30, the mixture of the two
hydroxylactones 7b (44.1%) and 8b (55.9 %) was created.
The separation of this mixture of lactones led to obtain pure
products: 7b (0.031 g, yield 28.2%) and 8b (0.041 g, yield
37.3%). We were able to isolate these two products and deter-
mine their structures. Product 7b was created from the minorTable 3 Assessment of the effects of unsaturated lactones 6a, 6b an
and filamentous fungi.
Grey colour indicated complete inhibition of growth of the microorganis
Please cite this article in press as: K. Win´ska et al., Antimicrobial activity of new bic
biosynthetically, Journal of Saudi Chemical Society (2016), http://dx.doi.org/10.101substrate 6b-A, while the major substrate 6b-B was trans-
formed into product 8b. In the case of lactone 6b-A, the signal
from proton H-7 was a multiplet that looked like a quintet, the
same as for hydroxylactone 7b (multiplet). In the case of unsat-
urated lactone 6b-B and hydroxylactone 8b, the signal from
proton H-7 was a quartet of doublets with coupling constants
7.6 and 1.6 Hz for both of them. This shows that even a small
change in the structure of the substrate has a large impact on
the structure of resulting product. The unexpected product 9b
was obtained when S. racemosum AM105 was used for bio-
transformation. This product was created with yield 48.5%
according to GC. Pure compound was obtained with yield
11.8% (0.013 g).
We were able to evaluate an enantiomeric excess and opti-
cal rotation only for one of the obtained products of biotrans-
formation: hydroxylactone 9b. These values are as follows:
ee ¼ 47:3% and ½a20D ¼ 4:953; c ¼ 0:17%.3.3. Biological activity
Because of the fact that of the several tested microorganisms
only a few proved to be capable of performing changes to
the structure of lactones 6a and 6b, we decided to check their
antimicrobial properties. We tested these lactones on different
bacteria, yeast and fungi strains for their ability to inhibit or
reduce the growth of the selected microorganisms. Hydroxy-
lactones 7a, 7b and 8b obtained during biotransformation were
also subjected to these biological tests. Hydroxylactone 9b was
obtained only in small quantities, which were insufficient to
perform biological tests with this compound. The results of
these tests are shown in Table 3.d hydroxylactones 7a, 7b and 8b on the growth of bacteria, yeast
m by the compound.
yclic lactones with three or four methyl groups obtained both synthetically and
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8 K. Win´ska et al.The biological tests performed on unsaturated lactones
showed that lactone 6a inhibited growth of only one bacterial
strain (P. fluorescens) and one filamentous fungal strain (F.
linii). In the case of lactone 6b the results were better. This
compound inhibited growth of two yeast strains (C. albicans
and Y. lipolytica) and three filamentous fungal strains
(Alternaria sp., F. linii and Penicillium sp.). It was very interest-
ing that both compounds showed activity against the F. linii,
which explains why it was impossible for the different Fusar-
ium species chosen by us to carry out the biotransformation
of lactones 6a and 6b.
Bioassay tests performed on the hydroxylactones obtained
during biotransformation showed that the best results were
obtained for compounds 7a, 7b and 8a, when they were used
against bacteria strains (except E. coli). All three hydroxylac-
tones inhibited growth of B. subtilis and P. fluorescens.
Additionally, compound 7b was active against S. aureus. All
three of the tested lactones were inactive against yeast strains
and most of the fungal strains. Only in the case of lactones
7a and 7b, growth inhibition of F. linii was observed.
3.4. Odour characteristic
An olfactory analysis of the new compounds was also
performed. The most interesting compounds in regard to their
scent were the two esters 3a and 3b. These compounds were
characterized by a fruity smell, with a distinct hint of pear in
the case of ester 3b. A fruity note was observed also for
hydroxylactone 7b, but opposite to esters there were dry
woody notes. Hydroxylactone 9b was characterized by other
interesting smells associated with the forest (notes of dry nee-
dles and resins). Interestingly, all of the hydroxylactones were
characterized by a dry, sometimes woody, scent. Unfortu-
nately, unsaturated lactones 7a and 7b were almost odourless.
For many years we’ve been obtaining the compounds with
interesting odouriferous properties by chemical synthesis
[40,31,41]. Our previous research made us suppose that mole-
cules such as ethyl esters 3a and 3b are characterized by a
fruity odour. The smell of hydroxylactones turned out to be
in line with our previous results [42].
4. Conclusions
Two unsaturated lactones (6a and 6b) were obtained through a
five-step synthesis. The second compound (6b) was created as a
pair of diastereoisomers, named 6b-A and 6b-B. These lactones
(6a and 6b) were subjected to a screening biotransformation
using 17 fungal strains. It appears that only three of these
strains were able to transform the unsaturated lactones into
hydroxy derivatives. The chosen microorganism showed very
high regiospecificity. When lactone 6a was used as the sub-
strate, generation of only the hydroxylactone was observed.
The two fungal strains P. vermiculatum AM30 and P. ostrea-
teus AM600 were able to perform hydroxylation of lactone
6a in one of the two possible allylic positions (methyl group
CH3-9). In the case of the diastereoisomeric mixture of lactone
6b-A and 6b-B, creation of three hydroxylactones was
observed. Biotransformation with the P. vermiculatum AM30
strain led to the generation of two different hydroxylactones.
Each of these was the result of hydroxylation of two possible
allylic positions. In the case of isomer 6b-A, methyl groupPlease cite this article in press as: K. Win´ska et al., Antimicrobial activity of new bic
biosynthetically, Journal of Saudi Chemical Society (2016), http://dx.doi.org/10.101CH3-9 was hydroxylated, in the case of isomer 6b-B methyl
group CH3-11 was hydroxylated. The second strain (S. race-
mosum AM105) was able to transform lactone 6b to an unex-
pected product, in which the hydroxy group attacked the
tertiary carbon C-7. This compound was obtained with enan-
tiomeric excess equal to 47.3% and with a predominance of
the () isomer. The biological tests performed on unsaturated
lactone 6a and hydroxylactones 7a, 7b and 8a showed that
these lactones inhibited the growth of the pathogenic bacterial
strains (S. aureus, P. fluorescens) and only one of the filamen-
tous fungal strains (F. linii). Unsaturated lactone 6b inhibited
the growth of pathogenic yeast strain (C. albicans) and strains
of filamentous fungi (Alternaria sp., Penicillium sp.). The fact
that all of the lactones inhibited growth of the F. linii strain
could explain the earlier observation that the unsaturated lac-
tones 6a and 6b could not be biotransformed by different
Fusarium strains. Olfactory analysis carried out on all of the
new products proved that the most interesting smell, a pre-
dominantly fruity aroma, characterized esters 3a and 3b and
hydroxylactone 7b. The scent of hydroxylactone 9b was also
interesting, as it was endowed with a forest scent.Acknowledgement
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